FTC sues big pharmacy profit professionals about insulin rates The agency introduced action against Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating procedures “artificially inflated” the list cost of daily life-conserving insulin drugs. Listen to the write-up ten min This audio is automobile-produced. Remember to allow https://label-the-figure-with-the16050.ziblogs.com/30735393/an-unbiased-view-of-healthcare-news